Moreover, the pharmacological induction of TSLP promotes B16F10 melanoma cell growth in syngenic wild-type mice, but not in TSLP−/− mice, and it has no effect on melanoma growth in immunodeficient mice, demonstrating the requirement of an intact immune system for TSLP to exert its pro-tumoral effect. The gene discussed is TSLP; the disease is melanoma.